Advertisement

Genetics of Type 2 Diabetes: the Power of Isolated Populations

  • Mette Korre Andersen
  • Casper-Emil Tingskov Pedersen
  • Ida Moltke
  • Torben Hansen
  • Anders Albrechtsen
  • Niels GrarupEmail author
Genetics (AP Morris, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Genetics

Abstract

Type 2 diabetes (T2D) affects millions of people worldwide. Improving the understanding of the underlying mechanisms and ultimately improving the treatment strategies are, thus, of great interest. To achieve this, identification of genetic variation predisposing to T2D is important. A large number of variants have been identified in large outbred populations, mainly from Europe and Asia. However, to elucidate additional variation, isolated populations have a number of advantageous properties, including increased amounts of linkage disequilibrium, and increased probability for presence of high frequency disease-associated variants due to genetic drift. Collectively, this increases the statistical power to detect association signals in isolated populations compared to large outbred populations. In this review, we elaborate on why isolated populations are a powerful resource for the identification of complex disease variants and describe their contributions to the understanding of the genetics of T2D.

Keywords

Type 2 diabetes Isolated populations Linkage disequilibrium Genetic drift Genome-wide association study Statistical power 

Notes

Acknowledgments

The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk). MKA was supported by a research grant from the Danish Diabetes Academy supported by the Novo Nordisk Foundation.

Compliance with Ethical Standards

Conflict of Interest

Mette Korre Andersen, Casper-Emil Tingskov Pedersen, Ida Moltke, Torben Hansen, Anders Albrechtsen, and Niels Grarup declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    IDF diabetes atlas, 7th edition. 2015. Available from: http://www.diabetesatlas.org/
  2. 2.
    Medici F, Hawa M, Ianari A, et al. Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia. 1999;42:146–50.CrossRefPubMedGoogle Scholar
  3. 3.
    Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981–90.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.•
    Mahajan A, Go MJ, Zhang W, et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014;46:234–44. The first major meta-analysis of type 2 diabetes genetics across multiple ancestries.CrossRefPubMedGoogle Scholar
  5. 5.
    Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76–80.CrossRefPubMedGoogle Scholar
  6. 6.
    Nielsen E-MD, Hansen L, Carstensen B, et al. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes. 2003;52:573–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Lim ET, Würtz P, Havulinna AS, et al. Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet. 2014;10:e1004494.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.••
    Lohmueller KE. The impact of population demography and selection on the genetic architecture of complex traits. PLoS Genet. 2014;10:e1004379. Carefully demonstrates the effect of recent population growth on the genetic architecture of complex traits.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Masel J. Genetic drift. Curr Biol. 2011;21:R837–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet. 1999;22:139–44.CrossRefPubMedGoogle Scholar
  11. 11.
    Zuk O, Schaffner SF, Samocha K, et al. Searching for missing heritability: designing rare variant association studies. Proc Natl Acad Sci. 2014;111:E455–64.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.•
    Moltke I, Fumagalli M, Korneliussen TS, et al. Uncovering the genetic history of the present-day Greenlandic population. Am J Hum Genet. 2015;96:54–69. Careful studies of the genetic history of the Greenlandic population.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Service S, DeYoung J, Karayiorgou M, et al. Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies. Nat Genet. 2006;38:556–60.CrossRefPubMedGoogle Scholar
  14. 14.
    Weiss KM, Terwilliger JD. How many diseases does it take to map a gene with SNPs? Nat Genet. 2000;26:151–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Lonjou C, Collins A, Morton NE. Allelic association between marker loci. Proc Natl Acad Sci. 1999;96:1621–6.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Skotte L, Korneliussen TSS, Moltke I, et al. Ancestry specific association mapping in admixed populations. bioRxiv; 2015. Available from: http://biorxiv.org/content/early/2015/01/22/014001
  17. 17.
    Newman DL, Abney M, McPeek MS, et al. The importance of genealogy in determining genetic associations with complex traits. Am J Hum Genet. 2001;69:1146–8.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Norio R. Finnish disease heritage I: characteristics, causes, background. Hum Genet. 2003;112:441–56.PubMedGoogle Scholar
  19. 19.
    Lohmueller KE. The distribution of deleterious genetic variation in human populations. Curr Opin Genet Dev. 2014;29:139–46.CrossRefPubMedGoogle Scholar
  20. 20.
    Casals F, Hodgkinson A, Hussin J, et al. Whole-exome sequencing reveals a rapid change in the frequency of rare functional variants in a founding population of humans. PLoS Genet. 2013;9:e1003815.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Szpiech ZA, Xu J, Pemberton TJ, et al. Long runs of homozygosity are enriched for deleterious variation. Am J Hum Genet. 2013;93:90–102.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Joshi PK, Esko T, Mattsson H, et al. Directional dominance on stature and cognition in diverse human populations. Nature. 2015;523:459–62.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Lohmueller KE, Indap AR, Schmidt S, et al. Proportionally more deleterious genetic variation in European than in African populations. Nature. 2008;451:994–7.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Simons YB, Turchin MC, Pritchard JK, et al. The deleterious mutation load is insensitive to recent population history. Nat Genet. 2014;46:220–4.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Fu W, Gittelman RM, Bamshad MJ, et al. Characteristics of neutral and deleterious protein-coding variation among individuals and populations. Am J Hum Genet. 2014;95:421–36.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.•
    Henn BM, Botigué LR, Bustamante CD, et al. Estimating the mutation load in human genomes. Nat Rev Genet. 2015;16:333–43. Highlights how deleterious mutations can evolve as if they were neutral, and shows why this leads to a correlation between burden of mutations and distance to Africa.CrossRefPubMedGoogle Scholar
  27. 27.
    Do R, Balick D, Li H, et al. No evidence that selection has been less effective at removing deleterious mutations in Europeans than in Africans. Nat Genet. 2015;47:126–31.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Henn BM, Botigué LR, Peischl S, et al. Distance from sub-Saharan Africa predicts mutational load in diverse human genomes. Proc Natl Acad Sci. 2016;113:E440–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Wright AF, Carothers AD, Pirastu M. Population choice in mapping genes for complex diseases. Nat Genet. 1999;23:397–404.CrossRefPubMedGoogle Scholar
  30. 30.
    Jørgensen ME, Borch-Johnsen K, Stolk R, et al. Fat distribution and glucose intolerance among Greenland Inuit. Diabetes Care. 2013;36:2988–94.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Schulz LO, Chaudhari LS. High-risk populations: the Pimas of Arizona and Mexico. Curr Obes Rep. 2015;4:92–8.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Cross HE. Population studies and the Old Order Amish. Nature. 1976;262:17–20.CrossRefPubMedGoogle Scholar
  33. 33.
    Hsueh WC, Mitchell BD, Aburomia R, et al. Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish family diabetes study. Diabetes Care. 2000;23:595–601.CrossRefPubMedGoogle Scholar
  34. 34.
    Amish Studies. 2016. Available from: http://groups.etown.edu/amishstudies.
  35. 35.
    Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341–5.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Diabetes Genetics Initiative of Broad Institute of Harvard and MIT and Novartis Institutes of BioMedical Research LU, Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316:1331–6.CrossRefGoogle Scholar
  37. 37.
    Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38:320–3.CrossRefPubMedGoogle Scholar
  38. 38.••
    Steinthorsdottir V, Thorleifsson G, Sulem P, et al. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat Genet. 2014;46:294–8. A well-designed study demonstrating the power of combining cutting-edge genotyping technology and extensive genealogical information to identify rare and low-frequency variants associated with type 2 diabetes.CrossRefPubMedGoogle Scholar
  39. 39.
    Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007;39:770–5.CrossRefPubMedGoogle Scholar
  40. 40.••
    Flannick J, Thorleifsson G, Beer NL, et al. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet. 2014;46:357–63. Major study identifying type 2 diabetes protective rare loss-of-function variants in beta cell expressed SLC30A8, and pinpoints this protein as a potential treatment target.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.••
    Moltke I, Grarup N, Jørgensen ME, et al. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature. 2014;512:190–3. Elegant study identifying a type 2 diabetes risk variant in TBC1D4, and determining its functional role in relation to diabetes, and thereby demonstrating the power of the Greenlandic population in genetic association studies.CrossRefPubMedGoogle Scholar
  42. 42.
    Hanson RL, Muller YL, Kobes S, et al. A genome-wide association study in American Indians implicates DNER as a susceptibility locus for type 2 diabetes. Diabetes. 2014;63:369–76.CrossRefPubMedGoogle Scholar
  43. 43.•
    Baier LJ, Muller YL, Remedi MS, et al. ABCC8 R1420H loss-of-function variant in a Southwest American Indian community: association with increased birth weight and doubled risk of type 2 diabetes. Diabetes. 2015;64:4322–32. Example of successful identification of a type 2 diabetes associated variant by targeted sequencing in an isolated population.CrossRefPubMedGoogle Scholar
  44. 44.
    Rampersaud E, Damcott CM, Fu M, et al. Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes. 2007;56:3053–62.CrossRefPubMedGoogle Scholar
  45. 45.
    Wang SR, Agarwala V, Flannick J, et al. Simulation of Finnish population history, guided by empirical genetic data, to assess power of rare-variant tests in Finland. Am J Hum Genet. 2014;94:710–20.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Arcos-Burgos M, Muenke M. Genetics of population isolates. Clin Genet. 2002;61:233–47.CrossRefPubMedGoogle Scholar
  47. 47.
    Kittles RA, Bergen AW, Urbanek M, et al. Autosomal, mitochondrial, and Y chromosome DNA variation in Finland: evidence for a male-specific bottleneck. Am J Phys Anthropol. 1999;108:381–99.CrossRefPubMedGoogle Scholar
  48. 48.
    Helgason A, Nicholson G, Stefánsson K, et al. A reassessment of genetic diversity in Icelanders: strong evidence from multiple loci for relative homogeneity caused by genetic drift. Ann Hum Genet. 2003;67:281–97.CrossRefPubMedGoogle Scholar
  49. 49.
    Kushner JA, Ciemerych MA, Sicinska E, et al. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol. 2005;25:3752–62.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Huyghe JR, Jackson AU, Fogarty MP, et al. Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat Genet. 2013;45:197–201.CrossRefPubMedGoogle Scholar
  51. 51.
    Yaghootkar H, Stancáková A, Freathy RM, et al. Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion. Diabetes. 2015;64:2279–85.CrossRefPubMedGoogle Scholar
  52. 52.
    Thanabalasingham G, Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). BMJ. 2011;343:d6044.CrossRefPubMedGoogle Scholar
  53. 53.
    Edghill EL, Khamis A, Weedon MN, et al. Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with type 2 diabetes. Diabet Med. 2011;28:681–4.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Raghavan M, DeGiorgio M, Albrechtsen A, et al. The genetic prehistory of the New World Arctic. Science. 2014;345:1255832.CrossRefPubMedGoogle Scholar
  55. 55.
    Jeppesen C, Jørgensen ME, Bjerregaard P. Assessment of consumption of marine food in Greenland by a food frequency questionnaire and biomarkers. Int J Circumpolar Health. 2012;71:18361.CrossRefPubMedGoogle Scholar
  56. 56.•
    Fumagalli M, Moltke I, Grarup N, et al. Greenlandic Inuit show genetic signatures of diet and climate adaptation. Science. 2015;349:1343–7. This study demonstrates the existence of several genetic regions influenced by adaptation in the Greenlandic population.CrossRefPubMedGoogle Scholar
  57. 57.
    Sano H, Kane S, Sano E, et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem. 2003;278:14599–602.CrossRefPubMedGoogle Scholar
  58. 58.
    Williams RC, Long JC, Hanson RL, et al. Individual estimates of European genetic admixture associated with lower body-mass index, plasma glucose, and prevalence of type 2 diabetes in Pima Indians. Am J Hum Genet. 2000;66:527–38.CrossRefPubMedGoogle Scholar
  59. 59.
    Rong R, Hanson RL, Ortiz D, et al. Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes. 2009;58:478–88.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Haiman CA, Fesinmeyer MD, Spencer KL, et al. Consistent directions of effect for established type 2 diabetes risk variants across populations: the population architecture using Genomics and Epidemiology (PAGE) Consortium. Diabetes. 2012;61:1642–7.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Guo T, Hanson RL, Traurig M, et al. TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3,501 individuals. Diabetes. 2007;56:3082–8.CrossRefPubMedGoogle Scholar
  62. 62.
    Hanson RL, Bogardus C, Duggan D, et al. A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes. 2007;56:3045–52.CrossRefPubMedGoogle Scholar
  63. 63.
    Deng Z, Shen J, Ye J, et al. Association between single nucleotide polymorphisms of delta/notch-like epidermal growth factor (EGF)-related receptor (DNER) and Delta-like 1 Ligand (DLL 1) with the risk of type 2 diabetes mellitus in a Chinese Han population. Cell Biochem Biophys. 2015;71:331–5.CrossRefPubMedGoogle Scholar
  64. 64.
    Bar Y, Efrat S. The NOTCH pathway in β-cell growth and differentiation. Vitam Horm. 2014;95:391–405.CrossRefPubMedGoogle Scholar
  65. 65.
    Huang K, Nair AK, Muller YL, et al. Whole exome sequencing identifies variation in CYB5A and RNF10 associated with adiposity and type 2 diabetes. Obesity. 2014;22:984–8.CrossRefPubMedGoogle Scholar
  66. 66.
    Flanagan SE, Patch A-M, Mackay DJG, et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes. 2007;56:1930–7.CrossRefPubMedGoogle Scholar
  67. 67.
    Gloyn AL, Weedon MN, Owen KR, et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes. 2003;52:568–72.CrossRefPubMedGoogle Scholar
  68. 68.
    Florez JC, Burtt N, de Bakker PI, et al. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes. 2004;53:1360–8.CrossRefPubMedGoogle Scholar
  69. 69.
    Pearson ER. Dissecting the etiology of type 2 diabetes in the Pima Indian population. Diabetes. 2015;64:3993–5.CrossRefPubMedGoogle Scholar
  70. 70.
    Proks P, Reimann F, Green N, et al. Sulfonylurea stimulation of insulin secretion. Diabetes. 2002;51 Suppl 3:S368–76.CrossRefPubMedGoogle Scholar
  71. 71.
    Hegele RA, Cao H, Harris SB, et al. The hepatocyte nuclear factor-1 alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. JCEM. 1999;84:1077–82.PubMedGoogle Scholar
  72. 72.
    Estrada K, Aukrust I, Bjørkhaug L, et al. Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population. JAMA. 2014;311:2305–14.CrossRefPubMedGoogle Scholar
  73. 73.
    Génin E, Clerget-Darpoux F. Association studies in consanguineous populations. Am J Hum Genet. 1996;58:861–6.PubMedPubMedCentralGoogle Scholar
  74. 74.
    Damcott CM, Pollin TI, Reinhart LJ, et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes. 2006;55:2654–9.CrossRefPubMedGoogle Scholar
  75. 75.
    Mounier C, Lavoie L, Dumas V, et al. Specific inhibition by hGRB10zeta of insulin-induced glycogen synthase activation: evidence for a novel signaling pathway. Mol Cell Endocrinol. 2001;173:15–27.CrossRefPubMedGoogle Scholar
  76. 76.
    Deng Y, Bhattacharya S, Swamy OR, et al. Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action. J Biol Chem. 2003;278:39311–22.CrossRefPubMedGoogle Scholar
  77. 77.
    Langlais P, Dong LQ, Ramos FJ, et al. Negative regulation of insulin-stimulated mitogen-activated protein kinase signaling by Grb10. Mol Endocrinol. 2004;18:350–8.CrossRefPubMedGoogle Scholar
  78. 78.
    Prokopenko I, Poon W, Mägi R, et al. A central role for GRB10 in regulation of islet function in man. PLoS Genet. 2014;10:e1004235.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Mette Korre Andersen
    • 1
  • Casper-Emil Tingskov Pedersen
    • 2
  • Ida Moltke
    • 2
  • Torben Hansen
    • 1
    • 3
  • Anders Albrechtsen
    • 2
  • Niels Grarup
    • 1
    Email author
  1. 1.The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical SciencesUniversity of CopenhagenCopenhagenDenmark
  2. 2.The Bioinformatics Centre, Department of BiologyUniversity of CopenhagenCopenhagenDenmark
  3. 3.Faculty of Health SciencesUniversity of Southern DenmarkOdenseDenmark

Personalised recommendations